Search Contract Opportunities

2019 Vaccines for Adults

ID: 75D301-19-R-67894 • Type: Synopsis Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: June 25, 2019, 4:51 p.m. EDT

AWARD NOTICE:

Contract Award of 6 Centers for Disease Control Vaccine for Adults (VFA) Contracts:

200-2019-05105 - Merck Sharp & Dohme Corp
Award Amount: $86,407,050.00

200-2019-05106 - Sanofi Pasteur Inc.
Award Amount: $36,351,538.70

200-2019-05107 - Dynavax Technologies Corporation
Award Amount: $26,156,250.00

200-2019-05108 - GlaxoSmithKline LLC
Award Amount: $112,644,450.00
200-2019-05109 - Grifols, USA
Award Amount: $1,602,700.00

200-2019-05110 - Pfizer Inc.
Award Amount: $46,031,000.00

This is a firm-fixed price, indefinite delivery/indefinite quantity delivery contract for the purchase of standard commercial vaccines described herein, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. The period of performance is 7/1/2019 - 6/30/2020.

Posted: April 3, 2019, 11:46 a.m. EDT
Posted: March 25, 2019, 12:20 p.m. EDT
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following adult vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:

Item Descriptions & Quantities:

1. Hepatitis A adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 775,000 Doses
Minimum: 100 Doses

2. Hepatitis B adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 375,000 Doses
Minimum: 100 Doses

3. Hepatitis A & B combination adult vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 275,000 Doses
Minimum: 100 Doses

4. Pneumococcal Polysaccharide vaccine:
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses

5. Tetanus and Diphtheria Toxoids vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 Doses
Minimum: 100 Doses

6. Herpes Zoster vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses

7. Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 Doses
Minimum: 100 Doses

8. Measles, Mumps, and Rubella
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 250,000 Doses
Minimum: 100 Doses

9. Meningococcal Conjugate (Groups A,C,Y &W)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses

10. Human Papillomavirus (HPV9)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 300,000 Doses
Minimum: 100 Doses

11. Varicella
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 150,000 Doses
Minimum: 10 Doses

12. Pneumococcal Conjugate (PCV13)
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 500,000 Doses
Minimum: 100 Doses

13. Serogroup B Meningococcal
Min. Shelf Life: 12 Months
Fed. Excise Tax: tiny_mce_marker.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses

All Vaccines are required to be delivered within 15 days after receipt of order.

The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination, as directed by delivery orders. The period of performance shall be 12 months from time of award. Any questions regarding this notice shall be submitted in writing to Christina McMichael at wpn6@cdc.gov. Telephone inquiries will not be honored.

Overview

Response Deadline
June 25, 2019, 6:00 p.m. EDT (original: April 8, 2019, 6:00 p.m. EDT) Past Due
Posted
March 25, 2019, 12:20 p.m. EDT (updated: June 25, 2019, 4:51 p.m. EDT)
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Fixed Price
Est. Level of Competition
Low
Vehicle Type
Indefinite Delivery Contract
On 3/25/19 CDC Office of Acquisition Services issued Synopsis Solicitation 75D301-19-R-67894 for 2019 Vaccines for Adults due 6/25/19. The opportunity was issued full & open with NAICS 325412 and PSC 65.
Primary Contact
Title
Contract Administrator
Name
Christina E. McMillian   Profile
Email
Phone
(770) 488-2697

Documents

Posted documents for Synopsis Solicitation 75D301-19-R-67894

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

IDV Awards

Indefinite delivery vehicles awarded through Synopsis Solicitation 75D301-19-R-67894

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation 75D301-19-R-67894

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation 75D301-19-R-67894

Experts for 2019 Vaccines for Adults

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > CENTERS FOR DISEASE CONTROL AND PREVENTION > Procurement and Grants Office (Atlanta)
Source Organization Code
a421ac56b6b15ff066ae8241912523c2
Last Updated
June 25, 2019
Last Updated By
PI33_DR_IAE_51681
Archive Date
June 25, 2019